Pisano Wayne — SEC insider filings
SEC reporting owner CIK 1743611. 17 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2020-09-28 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 45,000 shares, $62,098 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 30,352 shares, $402,753 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 20,000 shares @ $15.01 ($300,268) in Altimmune, Inc., filed 2022-12-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Altimmune, Inc. (ALT) | Director | 12 | 2 legs · 15,000 sh · $36,760 | 2 legs · 30,352 sh · $402,753 | 11 |
| ONCOLYTICS BIOTECH INC (ONCY) | Director | 2 | 1 leg · 30,000 sh · $25,338 | — | 1 |
| Provention Bio, Inc. (PRVB) | Director | 3 | — | — | 8 |
Insider filings — Pisano Wayne
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Altimmune, Inc. (ALT) | Purchase (P): 10,000 @ $1.64 | EDGAR |
| 2026-06-03 | 4 | ONCOLYTICS BIOTECH INC (ONCY) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-05-01 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 48,800 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | ONCOLYTICS BIOTECH INC (ONCY) | Purchase (P): 30,000 @ $0.84 | EDGAR |
| 2026-01-09 | 4 | Altimmune, Inc. (ALT) | Purchase (P): 5,000 @ $4.08 | EDGAR |
| 2025-09-29 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 48,800 (derivative) @ $0 | EDGAR |
| 2024-09-30 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 34,900 (derivative) @ $0 | EDGAR |
| 2023-09-29 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 26,100 (derivative) @ $0 | EDGAR |
| 2023-04-27 | 4 | Provention Bio, Inc. (PRVB) | Code (U): 7,500 · Disposition to issuer (D): 128,981 (derivative) · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 22,200 (derivative) · Disposition to issuer (D): 23,000 (derivative) · Disposition to issuer (D): 33,000 (derivative) | EDGAR |
| 2022-12-22 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 20,000 @ $2.60 · Sale (S): 20,000 @ $15.01 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2022-09-30 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 23,500 (derivative) @ $0 | EDGAR |
| 2022-05-18 | 4 | Provention Bio, Inc. (PRVB) | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2021-09-24 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 24,100 (derivative) @ $0 | EDGAR |
| 2021-05-14 | 4 | Provention Bio, Inc. (PRVB) | Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
| 2020-11-13 | 4 | Altimmune, Inc. (ALT) | Sale (S): 10,352 @ $9.90 | EDGAR |
| 2020-10-16 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 16,850 @ $0 · Option exercise (M): 16,850 (derivative) @ $0 | EDGAR |
| 2020-09-28 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 25,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1743611 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs